Delivery Order SPE2DB20D1109-SPE2DB24FP60P

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,753.02 firm fixed-price delivery order is for the supply of 4,562,834,751 units of Clarithromycin 500 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which runs through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,754.67 firm fixed-price delivery order is for the supply of Clarithromycin 500 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,907.34 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract provides for the supply of Clarithromycin 500 mg tablets, a generic antibiotic medication. This order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,875.13 firm fixed price delivery order contract is for the supply of Clarithromycin 500 mg tablets. The contract has a completion date of September 12, 2024 and was awarded on September 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
The U.S. Defense Logistics Agency (DLA) awarded a $5,451.36 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,639,679 units of Clarithromycin 500 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $1,451.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clarithromycin 500 mg tablets, a common antibiotic medication, and has a performance period through May 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,137.12 firm fixed price delivery order is for the supply of 60 tablets of the antibiotic medication Clarithromycin 500 mg. The award is not associated with a set-aside program and has an ultimate completion date of November 26, 2024. Amerisourcebergen maintains a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of clarithromycin 500 mg tablets. The contract, valued at $4,388.49, was awarded on May 8, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned for this award. Amerisourcebergen, one of the largest pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,248.91, is for the delivery of Clarithromycin 500mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Clarithromycin 500 mg tablets in 60-count packages. The contract has a ceiling value of $1,112.34 and an ultimate completion date of April 22, 2024. The contract was awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), which is part of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP60P
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,267.27 firm fixed-price delivery order contract is for the supply of Clarithromycin 500 mg tablets. The award is not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:12 PM